The case for a fractional regulatory officer

Early-stage medtech teams often need senior regulatory judgment long before they can justify a full-time director's salary. The usual fallback is to stretch a junior hire, lean on a founder who is already overcommitted, or buy scattered consulting hours that never quite add up to direction. A fractional regulatory officer is a different answer: senior leadership, embedded and part-time, with a real title and real authority.

What a fractional regulatory officer is

A fractional regulatory officer is not a one-off consultant who hands you a report and leaves. The role is embedded in your team on a recurring, part-time basis, carrying the same accountability a full-time regulatory leader would, sized to what an early company can actually support. You get continuity, context, and someone who owns outcomes rather than billing tasks.

Named accountability, not just advice

The difference that matters most is accountability. A fractional regulatory officer can hold named roles, including the EU MDR Article 15 Person Responsible for Regulatory Compliance, and can act as your management representative in front of auditors and notified bodies. That named responsibility is exactly what investors, partners, and regulators expect to see, and it is what separates genuine leadership from advisory hours.

What it looks like in practice

In a typical engagement, the fractional officer sets the direction of your quality system, owns submission strategy, represents the company in audits, and builds processes designed to scale into a full electronic quality system rather than to be rebuilt later. The work is practical and outcomes-first, with clear next steps instead of compliance theater.

• Senior regulatory judgment, sized to a startup budget.
• Named accountability, including EU MDR Article 15 PRRC.
• Systems designed to scale into an eQMS, not to be rebuilt.
• Continuity across submissions, audits, and reviews.

When the model fits

The fractional model fits companies roughly from seed through Series B: teams that are standing up a quality system for the first time, preparing for a submission, or entering a market that demands named regulatory leadership, but that are not yet ready or able to hire a full-time VP or Director. When the day comes that a full-time role is justified, a well-run fractional engagement leaves you with the systems and records to hand off cleanly.

Back to Insights